Proceedings of the European Association for the Study of the Liver, Paris, September 1993. This conference was attended by leading world specialists, who gave papers on the advances made in the treatment of hepatitis B and C, benign tumours of the liver, lesions produced by medical treatment, and liver transplants. This book, which has a strong clinical focus, gives hepatologists and gastroenterologists the opportunity to provide a rapid overview of the most innovative work described by the major international research teams.
Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. This extensive title, which combines scientific principles with up-to-date clinical procedures, has been thoroughly updated for the fourteenth edition. You’ll find in-depth material on the biology and pathophysiology of lymphomas, leukemias, platelet destruction, and other hematological disorders as well as the procedures for diagnosing and treating them.
The prescription drug market -- Proposed solutions for rising drug prices -- Measuring the value of prescription drugs -- Measuring drug value : whose job is it anyway? -- Institute for Clinical and Economic Review (ICER) -- Other US value assessment frameworks -- Do drugs for special populations warrant higher prices? -- Improving value measurement -- Aligning prices with value -- The path forward.
This book integrates insights from dialogic theory and systemic functional linguistics (SFL) to extend our understandings of engagement in medical research articles, going beyond notions of the role of verbal dialogue to encompass mathematical and visual semiotics and consider text not just as language but as multisemiosis. The volume begins by outlining the engagement framework and offering a brief overview of historical developments in medical research discourse. This discussion culminates in the introduction of the corpus used for analysis, drawing on original research articles from key medical journals to explore verbal, mathematical, and visual engagement in turn. A subsequent chapter brings these perspectives together to demonstrate intersemiotic engagement across different stages and phases of the medical research article and how such resources work together to construe and maintain the authoritative position commonly associated with medical discourse. The book looks ahead to engagement in other related disciplinary fields and future directions for work on multisemiosis and medical research discourse more generally. This book will be of particular interest to graduate students and researchers in multimodality, critical discourse analysis, applied linguistics, SFL, and science education.
Comprehensive in scope and thoroughly up to date, Wintrobe’s Clinical Hematology, 15th Edition, combines the biology and pathophysiology of hematology as well as the diagnosis and treatment of commonly encountered hematological disorders. Editor-in-chief Dr. Robert T. Means, Jr., along with a team of expert section editors and contributing authors, provide authoritative, in-depth information on the biology and pathophysiology of lymphomas, leukemias, platelet destruction, and other hematological disorders as well as the procedures for diagnosing and treating them. Packed with more than 1,500 tables and figures throughout, this trusted text is an indispensable reference for hematologists, oncologists, residents, nurse practitioners, and pathologists.
Trois cent cinquante millions de porteurs chroniques dans le monde, environ un million de décès chaque année, un vaccin efficace mais décrié en France, des traitements de plus en plus performants mais inaccessibles dans les régions les plus touchées par l’endémie... Près d’un demi-siècle après la découverte du virus de l'hépatite B, les défis posés par l'infection restent considérables. L'estimation récente de l'Institut de veille sanitaire a montré que la prévalence de l'infection par le virus de l'hépatite B était voisine de celle de l'infection par le virus de l'hépatite C en France. Les populations migrantes et les couches les plus défavorisées de la société sont les plus touchées. Le développement récent de molécules antivirales puissantes possédant une barrière génétique élevée contre la résistance permet en théorie de contrôler la très grande majorité des hépatites chroniques B. Cependant, l'obligation de traiter longtemps, sans doute à vie, une infection a priori incurable pose des problèmes difficiles d'indication thérapeutique, d'observance et de résistance. Aux campagnes de vaccination massive des nouveau-nés, enfants et adolescents dans la plupart des pays d'Asie, d'Europe et d'Afrique, la France oppose un décalage qui devrait être rapidement corrigé. La publication d'un ouvrage de référence sur l'hépatite B, après celui sur l'hépatite C, s'imposait donc. Les meilleurs spécialistes français se sont réunis pour faire le point sur les connaissances les plus récentes, sous l'oeil bienveillant de Harvey Alter, co-découvreur du virus de l'hépatite B avec Baruch Blumberg, prix Nobel de Médecine, alors que l'European Association for the Study of the Liver (EASL) publiait ses première recommandations de pratiques cliniques sur la prise en charge de l'hépatite chronique B et que notre ministre lançait, pour les années 2009-2012, un nouveau plan de lutte contre les hépatites virales. La publication de cet ouvrage arrive, nous semble-t-il, bien à propos.
Proceedings of the European Association for the Study of the Liver, Paris, September 1993. This conference was attended by leading world specialists, who gave papers on the advances made in the treatment of hepatitis B and C, benign tumours of the liver, lesions produced by medical treatment, and liver transplants. This book, which has a strong clinical focus, gives hepatologists and gastroenterologists the opportunity to provide a rapid overview of the most innovative work described by the major international research teams.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.